Association between Sarcomeric Variants in Hypertrophic Cardiomyopathy and Myocardial Oxygenation: Insights from a Novel Oxygen-Sensitive Cardiovascular Magnetic Resonance Approach

Betty Raman, Elizabeth M. Tunnicliffe, Kenneth Chan, Rina Ariga, Moritz Hundertmark, Eric O. Ohuma, Sanjay Sivalokanathan, Yi Jie Gifford Tan, Masliza Mahmod, Aaron T. Hess, Theodoros D. Karamitsos, Joseph Selvanayagam, Michael Jerosch-Herold, Hugh Watkins, Stefan Neubauer

Research output: Contribution to journalLetterpeer-review

7 Citations (Scopus)

Abstract

Elucidating the effects of sarcomeric variants on the hypertrophic cardiomyopathy (HCM) pheno-type is a major research priority with potential to accelerate disease-specific therapeutic development. We and others, have previously described the adverse impact of sarcomeric (Sarc+) mutations on myocardial oxygenation among patients with HCM after vasodilator stress using a standard oxygen-sensitive cardiovascular magnetic resonance (CMR) approach. Although widely used, vasodilator stress oxygenation measured by T2-prepared steady-state free precession blood oxygen level–dependent imaging (T2-prep SSFP BOLD) suffers from low precision attributable to coil sensitivity (B1−) variations and heart rate (HR) changes. B1 variation matters when breath-hold positions differ during vasodilator provocation.
Original languageEnglish
Pages (from-to)1656-1658
Number of pages3
JournalCirculation
Volume144
Issue number20
DOIs
Publication statusPublished - 16 Nov 2021

Keywords

  • BOLD protocol
  • cardiomyopathy, hypertrophic
  • magnetic resonance imaging
  • perfusion
  • sarcomeric HCM

Fingerprint

Dive into the research topics of 'Association between Sarcomeric Variants in Hypertrophic Cardiomyopathy and Myocardial Oxygenation: Insights from a Novel Oxygen-Sensitive Cardiovascular Magnetic Resonance Approach'. Together they form a unique fingerprint.

Cite this